It stops the body being told to produce an enzyme known to play a key role in coronavirus and other respiratory infections, enabling the virus to enter host cells and proliferate
I’m Paul Hutton with news that a new inhaler therapy that alters genetic data in the lungs to stop coronavirus taking hold is being developed. The Telegraph reports the treatment works by sending nanoparticles into the lungs containing tiny molecular scissors that snip away genetic messages. It stops the body being told to produce an enzyme known to play a key role in coronavirus and other respiratory infections, enabling the virus to enter host cells and proliferate. For more care related stories stay with us here at Care Radio.